ADVISE_V1.1
Research type
Research Study
Full title
What do patients with alcohol related liver disease (ArLD) and clinicians working with this patient group perceive to be the barriers and facilitators to accessing alcohol support following an inpatient hospital admission?
IRAS ID
311440
Contact name
Nurun Tania
Contact email
Sponsor organisation
Hull University Teaching Hospitals NHS Trusts
Duration of Study in the UK
1 years, 3 months, 1 days
Research summary
Alcohol related liver disease (ArLD) accounts for 60% of all liver diseases and is caused by the excessive and prolonged use of alcohol. Individuals may not experience symptoms until the disease is well established, causing permanent and life limiting damage. The most effective treatment strategy is abstinence from alcohol, however, achieving abstinence for many, can be difficult. There are various services that provide support for abstinence; but are often underutilized. The reasons services are not fully utilized are poorly understood. There is limited literature on the perceptions of health care professionals (HCP) in supporting ArLD patients in accessing appropriate support following a hospital admission. This study aims to explore patients experiences of accessing alcohol support following an inpatient hospital admission, and barriers and facilitators in referring to alcohol support services from an HCP perspective. Recruitment will take place at Hull University Teaching Hospitals NHS Trusts.
This protocol describes two related studies.
Study 1: Semi-structured interviews with up to 30 adults diagnosed with ArLD and a hospital admission in the last 18 months. Patients will be identified by the patient’s clinical team from both inpatient outpatient settings. Consenting participants will be invited to attend an interview ~60 minutes. Questions from a topic guide developed with patient public involvement (PPI) members will be used to ask questions relating to their perceived barriers and facilitators of using alcohol support services.
Study 2 HCP involved in the care of patients with ArLD will be asked to participate in 1 of 3 face-face focus groups that explore the perceived barriers and facilitators for HCP involved in the care of the patient population in referring patients to alcohol support services. Participants will including Doctors, Nurses and allied HCP.
The results of this study will identify key barriers and facilitators from the patient and HCP perspective. The findings will inform recommendations for the development of care pathways for patients diagnosed with ArLD.REC name
East of Scotland Research Ethics Service REC 1
REC reference
23/ES/0006
Date of REC Opinion
28 Mar 2023
REC opinion
Further Information Favourable Opinion